미용용 바늘 및 캐뉼라 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 소재별, 게이지 사이즈별, 최종 용도별 및 부문별 예측(2026-2033년)

Aesthetic Needles And Cannulas Market Summary

The global aesthetic needles and cannulas market size was estimated at USD 480 million in 2025 and is projected to reach USD 1,037.42 million by 2033, growing at a CAGR of 10.03% from 2026 to 2033. The growth of this market is primarily driven by the rising demand for minimally invasive cosmetic procedures, increasing consumer awareness regarding aesthetic treatments, and the growing aging population seeking anti-aging solutions.

In addition, advancements in needle and cannula design that enhance safety and precision, along with the expanding availability of dermal fillers and injectables, are further fueling market expansion. The increasing influence of social media, medical tourism, and the rising number of skilled aesthetic practitioners also contribute significantly to the market's growth trajectory.

The growing volume of aesthetic injectable procedures is significantly driving the aesthetic needles and cannulas market, as treatments such as botulinum toxin and dermal fillers rely entirely on these devices for precise delivery. The increasing preference for quick, non-surgical enhancements has led to higher procedure frequency and repeat treatments, directly boosting the consumption of disposable needles and microcannulas. This sustained rise in injectable demand continues to accelerate market expansion and product innovation.

lobal Aesthetic Needles And Cannulas Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global aesthetic needles and cannulas market report on the basis of product, gauze size, material, end use and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Cannulas
  • By Application
  • Dermal Fillers (General)
  • Hyaluronic Acid
  • Non Hyaluronic Acid
  • Skin Boosters / Mesotherapy
  • Tear Trough / Under-Eye Fillers
  • Lip Augmentation
  • Facial Contouring (Cheek, Jawline, Chin)
  • Others
• Sharp Needles
  • By Application
  • Botulinum Toxin Injections
  • Skin Boosters / Mesotherapy
  • PRP (Platelet Rich Plasma)
  • Dermal Filler Injections (Certain Areas)
  • Micro-Botox / Intradermal Injections
• Gauze Size Outlook (Revenue, USD Million, 2021 - 2033)
• 34G - 32G
• 31G - 29G
• 28G - 25G
• 24G - 21G
• 20G and above
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Stainless Steel
• Silicon-Coated
• Specialty Alloy
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• MedSpas/Aesthetic Clinics
• Aesthetic Surgery Centers
• Hospitals
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Gauze Size
  • 1.1.3. Material
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Aesthetic Needles and Cannulas Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Demand for Minimally Invasive Cosmetic Procedures
    • 3.2.1.2. Growth in Aesthetic Clinics and Medical Spas
    • 3.2.1.3. Increasing Awareness of Aesthetic Treatments
    • 3.2.1.4. Advancements in Injection Technologies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risk of Complications Associated with Injectable Procedures
    • 3.2.2.2. Strict Regulatory Requirements
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Increasing Adoption of Cannula-Based Injection Techniques
    • 3.2.3.2. Expansion of Aesthetic Treatments in Emerging Demographics
    • 3.2.3.3. Growth of Training Programs and Aesthetic Education
    • 3.2.3.4. Innovation in Product Design
    • 3.2.3.5. Shift Towards Premium Products
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Shortage of Skilled Aesthetic Practitioners
    • 3.2.4.2. Competition from Alternative Aesthetic Technologies
    • 3.2.4.3. Geopolitical Challenges
• 3.3. Aesthetic Needles and Cannulas Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Aesthetic Needles and Cannulas Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Aesthetic Needles and Cannulas Market: Product Movement Analysis
• 4.3. Aesthetic Needles and Cannulas Market by Product Outlook (USD Million)
• 4.4. Aesthetic Needles and Cannulas Market by Product Outlook (Volume Unit)
• 4.5. Aesthetic Needles and Cannulas Market by Product Outlook (ASP USD)
• 4.6. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.7. Cannulas
  • 4.7.1. Cannulas Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
  • 4.7.2. By Application
    • 4.7.2.1. Dermal Fillers (General)
      • 4.7.2.1.1. Dermal Fillers (General) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
      • 4.7.2.1.2. Hyaluronic Acid
        • 4.7.2.1.2.1. Hyaluronic Acid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
      • 4.7.2.1.3. Non Hyaluronic Acid
        • 4.7.2.1.3.1. Non Hyaluronic Acid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.7.2.2. Skin Boosters / Mesotherapy
      • 4.7.2.2.1. Skin Boosters / Mesotherapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.7.2.3. Tear Trough / Under-Eye Fillers
      • 4.7.2.3.1. Tear Trough / Under-Eye Fillers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.7.2.4. Lip Augmentation
      • 4.7.2.4.1. Lip Augmentation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.7.2.5. Facial Contouring (Cheek, Jawline, Chin)
      • 4.7.2.5.1. Facial Contouring (Cheek, Jawline, Chin) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.7.2.6. Others
      • 4.7.2.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
• 4.8. Sharp Needles
  • 4.8.1. Sharp Needles Market Revenue Estimates and Forecasts, 2021 - (USD Million, Volume Unit, ASP USD)
  • 4.8.2. By Application
    • 4.8.2.1. Botulinum Toxin Injections
      • 4.8.2.1.1. Botulinum Toxin Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.8.2.2. Skin Boosters / Mesotherapy
      • 4.8.2.2.1. Skin Boosters / Mesotherapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.8.2.3. PRP (Platelet Rich Plasma)
      • 4.8.2.3.1. PRP (Platelet Rich Plasma) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.8.2.4. Dermal Filler Injections (Certain Areas)
      • 4.8.2.4.1. Dermal Filler Injections (Certain Areas) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)
    • 4.8.2.5. Micro-Botox / Intradermal Injections
      • 4.8.2.5.1. Micro-Botox / Intradermal Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit, ASP USD)

Chapter 5. Aesthetic Needles and Cannulas Market: Gauze Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Aesthetic Needles and Cannulas Market: Gauze Size Movement Analysis
• 5.3. Aesthetic Needles and Cannulas Market by Gauze Size Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. 34G - 32G
  • 5.5.1. 34G - 32G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. 31G - 29G
  • 5.6.1. 31G - 29G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. 28G - 25G
  • 5.7.1. 28G - 25G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. 24G - 21G
  • 5.8.1. 24G - 21G Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. 20G and above
  • 5.9.1. 20G and Above Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Aesthetic Needles and Cannulas Market: Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Aesthetic Needles and Cannulas Market: Material Movement Analysis
• 6.3. Aesthetic Needles and Cannulas Market by Material Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Stainless Steel
  • 6.5.1. Stainless Steel Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Silicon-Coated
  • 6.6.1. Silicon-Coated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Specialty Alloy
  • 6.7.1. Specialty Alloy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Aesthetic Needles and Cannulas Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Aesthetic Needles and Cannulas Market: End Use Movement Analysis
• 7.3. Aesthetic Needles and Cannulas Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. MedSpas/Aesthetic Clinics
  • 7.5.1. MedSpas/Aesthetic Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Aesthetic Surgery Centers
  • 7.6.1. Aesthetic Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Hospitals
  • 7.7.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Aesthetic Needles and Cannulas Market: Regional Estimates & Trend Analysis, by Product, by Gauze Size, by Material, and by End Use

• 8.1. Regional Dashboard
• 8.2. Regional Aesthetic Needles and Cannulas Market Movement Analysis & Market Share, 2025 & 2033
• 8.3. Aesthetic Needles and Cannulas Market: Regional Estimates & Trend Analysis
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. North America
  • 8.5.1. North America Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Europe
  • 8.5.6. Europe Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. UK
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. UK Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Germany
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Germany Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. France
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. France Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.10. Italy
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Reimbursement scenario
    • 8.5.10.5. Italy Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.11. Spain
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Reimbursement scenario
    • 8.5.11.5. Spain Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.12. Denmark
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Reimbursement scenario
    • 8.5.12.5. Denmark Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.13. Sweden
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Reimbursement scenario
    • 8.5.13.5. Sweden Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.14. Norway
    • 8.5.14.1. Key Country Dynamics
    • 8.5.14.2. Competitive Scenario
    • 8.5.14.3. Regulatory Framework
    • 8.5.14.4. Reimbursement scenario
    • 8.5.14.5. Norway Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Japan Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. China Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. India Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. South Korea Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Australia Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Thailand Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Brazil Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Argentina Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. South Africa Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Saudi Arabia Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. UAE Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Kuwait Aesthetic Needles and Cannulas Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Shre Analysis, 2025
• 9.3. Key Company Profiles
  • 9.3.1. TSK Laboratory International
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. JAPAN BIO PRODUCTS Co., Ltd.
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. SoftFil (Prollenium Medical Technologies)
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. BD
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Shanghai Mekon Medical Devices Co., Ltd. (Mekon Medical)
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Kindly (KDL) Group
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Sterimedix
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Aesthetic Group
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Grand Aespio
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Terumo
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. ZORAY Precision Technology Co., Ltd.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Needle Concept
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. DermaSculpt (CosmoFrance Inc.)
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. PDO Max, Inc.
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. Huons Meditech
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Product benchmarking
    • 9.3.15.4. Strategic initiatives